Abstract
Since radiopharmaceuticals are intended for administration to humans, it is imperative that they undergo strict quality control measures. Basically, quality control involves several specific tests and measurements that ensure the purity, potency, product identity, biologic safety, and efficacy of radiopharmaceuticals. All quality control procedures that are applied to nonradioactive pharmaceuticals are equally applicable to radiopharmaceuticals; in addition, tests for radionuclidic and radiochemical purity have to be carried out. Often these quality control tests are carried out by the manufacturers from the beginning of production all the way up to the finished product. However, the introduction of kits, the increasing use of short-lived radionuclides such as 99mTc and the on-site preparation of many radiopharmaceuticals require that most, if not all, quality control tests be performed on all in-house preparations before dispensing these products for human administration.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences and Suggested Reading
Avis KE, Leuchuk JW. Parenteral preparations. In: Avis KE, Lieberman HA, and Lachman L, eds. Remington: The Science and Practice of Pharmacy. 21st ed. Baltimore, MD: Lippincott, Williams and Wilkins; 2005.
Bobinet DD, Williams GC, Cohen MB. Comparison of commercial pyrogen testing laboratories. Am J Hosp Pharm. 1976; 33:801.
Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med 1990; 20:5.
Eckelman WC, Levenson SM, Johnston GS. Radiochemical purity of 99mTc-radiopharmaceuticals. Appl Radiol. 1977; 6:211.
Centre for Drug Evaluation and Research (CDER). Guideline on validation of the Limulus Amebocyte Lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. Rockville, MD: U.S. FDA; 1987.
Krogsgaard OW. Radiochemical purity of various 99mTc-labelled bone-scanning agents. Eur J Nucl Med. 1976; 1:15.
Pauwels EKJ, Feitsma RIJ. Radiochemical quality control of 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med. 1977; 2:97.
Meyer GJ, Coenen HH, Waters SL, et al. Quality assurance and quality control of short-lived radioharmaceuticals for PET. In: Stöcklin G, Pike VW, eds. Radiopharmaceuticals for Positron Emission Tomography: Methodical Aspects. Dordrecht, Netherlands: Kluwer; 1993: 91.
Robbins PJ. Chromatography of technetium 99mTc-radiopharmaceuticals – a practical guide. New York: Society of Nuclear Medicine; 1984.
United States Pharmacopeial Convention. U.S. Pharmacopeia 32 & National Formulary 27. Rockville, MD: The United States Pharmacopeial Convention; 2009.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Saha, G.B. (2010). Quality Control of Radiopharmaceuticals. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5860-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5860-0_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5859-4
Online ISBN: 978-1-4419-5860-0
eBook Packages: MedicineMedicine (R0)